|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Is Essential for Binding IL-15 and Inhibiting Inflammatory and Allogenic Responses In Vitro and In Vivo1


*
Department of Immunology and Bacteriology and
Center of Rheumatic Disease, University of Glasgow, Glasgow, United Kingdom
IL-15 is a pleiotropic cytokine that plays important roles in both
innate and adaptive immunity. It is associated with a range of
immunopathology, including rheumatoid arthritis and allograft
rejection. IL-15 functions through the trimeric IL-15R complex, which
consists of a high affinity binding
-chain and the common IL-2R
-
and
-chains. Characterization of IL-15/IL-15R interactions may
facilitate the development of improved IL-15 antagonists for
therapeutic interventions. We previously constructed soluble murine
IL-15R
(sIL-15R
) by deleting the cytoplasmic and transmembrane
domains. To localize the functional domain of IL-15R
, we have now
constructed various truncated versions of sIL-15R
. The shortest
region retaining IL-15 binding activity is a 65-aa sequence spanning
the Sushi domain of IL-15R
. Sushi domains, common motifs in
protein-protein interactions, contain four cysteines forming two
disulfide bonds in a 1-3 and 2-4 pattern. Amino acid substitution of
the first or fourth cysteine in sIL-15R
completely abolished its
IL-15 binding activity. This also abrogated the ability of sIL-15R
to neutralize IL-15-induced proinflammatory cytokine production and
anti-apoptotic response in vitro. Furthermore, the mutant
sIL-15R
lost its ability to inhibit carrageenan-induced local
inflammation and allogenic cell-induced T cell proliferation and
cytokine production in vivo. Thus, the Sushi domain is critical for the
functional activity of sIL-15R
.
This article has been cited by other articles:
![]() |
B. Royer-Zemmour, M. Ponsole-Lenfant, H. Gara, P. Roll, C. Leveque, A. Massacrier, G. Ferracci, J. Cillario, A. Robaglia-Schlupp, R. Vincentelli, et al. Epileptic and developmental disorders of the speech cortex: ligand/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR Hum. Mol. Genet., December 1, 2008; 17(23): 3617 - 3630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Olsen, N. Ota, S. Kishishita, M. Kukimoto-Niino, K. Murayama, H. Uchiyama, M. Toyama, T. Terada, M. Shirouzu, O. Kanagawa, et al. Crystal Structure of the Interleukin-15{middle dot}Interleukin-15 Receptor {alpha} Complex: INSIGHTS INTO TRANS AND CIS PRESENTATION J. Biol. Chem., December 21, 2007; 282(51): 37191 - 37204. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bulanova, V. Budagian, E. Duitman, Z. Orinska, H. Krause, R. Ruckert, N. Reiling, and S. Bulfone-Paus Soluble Interleukin (IL)-15R{alpha} Is Generated by Alternative Splicing or Proteolytic Cleavage and Forms Functional Complexes with IL-15 J. Biol. Chem., May 4, 2007; 282(18): 13167 - 13179. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Taylor, P. T. Walsh, D. F. LaRosa, J. Zhang, M. A. Burchill, M. A. Farrar, and L. A. Turka Constitutive Activation of STAT5 Supersedes the Requirement for Cytokine and TCR Engagement of CD4+ T Cells in Steady-State Homeostasis J. Immunol., August 15, 2006; 177(4): 2216 - 2223. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Rubinstein, M. Kovar, J. F. Purton, J.-H. Cho, O. Boyman, C. D. Surh, and J. Sprent Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha} PNAS, June 13, 2006; 103(24): 9166 - 9171. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Combe, M. M. Moretto, J. D. Schwartzman, J. P. Gigley, D. J. Bzik, and I. A. Khan Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite PNAS, April 25, 2006; 103(17): 6635 - 6640. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lorenzen, A. J. Dingley, Y. Jacques, and J. Grotzinger The Structure of the Interleukin-15{alpha} Receptor and Its Implications for Ligand Binding J. Biol. Chem., March 10, 2006; 281(10): 6642 - 6647. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tejman-Yarden, M. Zlotnik, E. Lewis, O. Etzion, C. Chaimovitz, and A. Douvdevani Renal cells express a functional interleukin-15 receptor Nephrol. Dial. Transplant., March 1, 2005; 20(3): 516 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iwasaki, T. Kuwata, Y. Yamazaki, N. A. Jenkins, N. G. Copeland, M. Osato, Y. Ito, E. Kroon, G. Sauvageau, and T. Nakamura Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model Blood, January 15, 2005; 105(2): 784 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Budagian, E. Bulanova, Z. Orinska, A. Ludwig, S. Rose-John, P. Saftig, E. C. Borden, and S. Bulfone-Paus Natural Soluble Interleukin-15R{alpha} Is Generated by Cleavage That Involves the Tumor Necrosis Factor-{alpha}-converting Enzyme (TACE/ADAM17) J. Biol. Chem., September 24, 2004; 279(39): 40368 - 40375. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Toomey, F. Gays, D. Foster, and C. G. Brooks Cytokine requirements for the growth and development of mouse NK cells in vitro J. Leukoc. Biol., August 1, 2003; 74(2): 233 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Nguyen, T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X.-q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron Coordinated and Distinct Roles for IFN-{alpha}{beta}, IL-12, and IL-15 Regulation of NK Cell Responses to Viral Infection J. Immunol., October 15, 2002; 169(8): 4279 - 4287. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gri, C. Chiodoni, E. Gallo, A. Stoppacciaro, F. Y. Liew, and M. P. Colombo Antitumor Effect of Interleukin (IL)-12 in the Absence of Endogenous IFN-{gamma}: A Role for Intrinsic Tumor Immunogenicity and IL-15 Cancer Res., August 1, 2002; 62(15): 4390 - 4397. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Khan, M. Moretto, X.-q. Wei, M. Williams, J. D. Schwartzman, and F. Y. Liew Treatment with Soluble Interleukin-15R{alpha} Exacerbates Intracellular Parasitic Infection by Blocking the Development of Memory CD8+ T Cell Response J. Exp. Med., June 3, 2002; 195(11): 1463 - 1470. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |